4FTAS_STRCT
ID 4FTAS_STRCT Reviewed; 634 AA.
AC B6VP39;
DT 05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT 16-DEC-2008, sequence version 1.
DT 03-AUG-2022, entry version 46.
DE RecName: Full=Fluorothreonine transaldolase;
DE EC=2.2.1.8;
DE AltName: Full=4-fluorothreonine transaldolase;
DE Short=4-FTase;
OS Streptomyces cattleya.
OC Bacteria; Actinobacteria; Streptomycetales; Streptomycetaceae;
OC Streptomyces.
OX NCBI_TaxID=29303;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 82-88; 303-312 AND
RP 369-383, FUNCTION, CATALYTIC ACTIVITY, AND COFACTOR.
RX PubMed=19101471; DOI=10.1016/j.chembiol.2008.10.012;
RA Deng H., Cross S.M., McGlinchey R.P., Hamilton J.T., O'Hagan D.;
RT "In vitro reconstituted biotransformation of 4-fluorothreonine from
RT fluoride ion: application of the fluorinase.";
RL Chem. Biol. 15:1268-1276(2008).
CC -!- FUNCTION: Transaldolase that catalyzes the final step in 4-
CC fluorothreonine biosynthesis. Mediates a L-threonine/fluoroaceldehyde
CC to 4-fluoro-L-threonine/acetaldehyde crossover reaction. Can also
CC convert chloroacetaldehyde into 4-chloro-L-threonine. Does not use
CC glycine as a substrate. {ECO:0000269|PubMed:19101471}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=fluoroacetaldehyde + L-threonine = 4-fluoro-L-threonine +
CC acetaldehyde; Xref=Rhea:RHEA:11748, ChEBI:CHEBI:14272,
CC ChEBI:CHEBI:15343, ChEBI:CHEBI:57264, ChEBI:CHEBI:57926; EC=2.2.1.8;
CC Evidence={ECO:0000269|PubMed:19101471};
CC -!- COFACTOR:
CC Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC Evidence={ECO:0000269|PubMed:19101471};
CC -!- SIMILARITY: Belongs to the SHMT family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; FM251921; CAR92347.1; -; Genomic_DNA.
DR AlphaFoldDB; B6VP39; -.
DR SMR; B6VP39; -.
DR BioCyc; MetaCyc:MON-15924; -.
DR BRENDA; 2.2.1.8; 5990.
DR GO; GO:0033806; F:fluorothreonine transaldolase activity; IEA:UniProtKB-EC.
DR GO; GO:0004372; F:glycine hydroxymethyltransferase activity; IEA:InterPro.
DR GO; GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro.
DR GO; GO:0019264; P:glycine biosynthetic process from serine; IEA:InterPro.
DR GO; GO:0035999; P:tetrahydrofolate interconversion; IEA:InterPro.
DR Gene3D; 3.40.225.10; -; 1.
DR Gene3D; 3.40.640.10; -; 1.
DR Gene3D; 3.90.1150.10; -; 1.
DR InterPro; IPR001303; Aldolase_II/adducin_N.
DR InterPro; IPR036409; Aldolase_II/adducin_N_sf.
DR InterPro; IPR030979; F_threo_transal.
DR InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR InterPro; IPR015421; PyrdxlP-dep_Trfase_major.
DR InterPro; IPR015422; PyrdxlP-dep_Trfase_small.
DR InterPro; IPR001085; Ser_HO-MeTrfase.
DR InterPro; IPR039429; SHMT-like_dom.
DR PANTHER; PTHR11680; PTHR11680; 1.
DR Pfam; PF00596; Aldolase_II; 1.
DR Pfam; PF00464; SHMT; 1.
DR SMART; SM01007; Aldolase_II; 1.
DR SUPFAM; SSF53383; SSF53383; 1.
DR SUPFAM; SSF53639; SSF53639; 1.
DR TIGRFAMs; TIGR04506; F_threo_transal; 1.
PE 1: Evidence at protein level;
KW Direct protein sequencing; Pyridoxal phosphate; Transferase.
FT CHAIN 1..634
FT /note="Fluorothreonine transaldolase"
FT /id="PRO_0000419110"
FT REGION 428..456
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT BINDING 67
FT /ligand="pyridoxal 5'-phosphate"
FT /ligand_id="ChEBI:CHEBI:597326"
FT /evidence="ECO:0000250"
FT BINDING 221
FT /ligand="pyridoxal 5'-phosphate"
FT /ligand_id="ChEBI:CHEBI:597326"
FT /evidence="ECO:0000250"
FT BINDING 247
FT /ligand="pyridoxal 5'-phosphate"
FT /ligand_id="ChEBI:CHEBI:597326"
FT /evidence="ECO:0000250"
FT BINDING 375
FT /ligand="pyridoxal 5'-phosphate"
FT /ligand_id="ChEBI:CHEBI:597326"
FT /evidence="ECO:0000250"
FT MOD_RES 248
FT /note="N6-(pyridoxal phosphate)lysine"
FT /evidence="ECO:0000250"
SQ SEQUENCE 634 AA; 69529 MW; B583B60850531B76 CRC64;
MPSSVNRTSR TEPAGHHREF PLSLAAIDEL VAEEEAEDAR VLHLTANETV LSPRARAVLA
SPLTSRYLLE HLDMRGPSPA RLGNLLLRGL DRIGTIEESA TEVCRRLFGA RYAEFRCLSG
LHAMQTTFAA LSRPGDTVMR VATKDGGHFL TELICRSFGR RSCTYVFDDT MTIDLERTRE
VVEKERPSLL FVDAMNYLFP FPIAELKAIA GDVPLVFDAS HTLGLIAGGR FQDPLREGAD
LLQANTHKTF FGPQKGIILG NDRSLMEELG YTLSTGMVSS QHTASTVALL IALHEMWYDG
REYAAQVIDN ARRLAGALRD RGVPVVAEER GFTANHMFFV DTRPLGSGPA VIQRLVRAGV
SANRAVAFNH LDTIRFGVQE ITRRGYDHDD LDEAADLVAA VLLERQEPER IRPRVAELVG
RRRTVRYTGD PASAAGPPAR ERYAPPTAPA GHPARPRWIG VRLTPLPEPV TEAECAGAQR
LGRLAGAFPH QIDSSGNVSF TSTDGRLFVT GSGTYIKDLA PGDFVELTGA EGWTLHCRGD
GPPSAEAYLH HLLRERVGAR YVVHNHCIPG RALETSGALV IPPKEYGSVA LAEAVADACQ
DSQVMYVRRH GLVFWAHSYD ECLALIEDVR RITG